Produit
AGENTS IA
APPLICATIONS DE L'IA
AUTRES
Solutions
SECTEURS D'ACTIVITÉ
USE CASES
Tarification
Ressources
EXPLORER
ENGAGER
ASSISTANCE ET SERVICES
À propos
Plateforme PatSnap Eureka
Mandataires en propriété intellectuelle
Agents pour l'ingénierie
Agents pour les sciences de la vie
Agents pour matériaux
Analytique
Intelligence IPSynapse
Renseignement biopharmaceutiqueBiographie
Recherche et analyse de séquences biologiquesChimique
Recherche et analyse de structures chimiquesPlateforme ouverte
NEWServices professionnels
Cabinets d'avocats
Sciences de la vie
Haute technologie
Competitor Tech Research
Design Risk Screening
Témoignages clients
Newsroom
Blog
Rapport mondial sur l'innovation
Glossaire
Webinaires et formations
Frontière
Communauté d'utilisateurs
Confiance et sécurité
PatentBench
NEWLLM
Centre d'aide
Carrières
Accès à plus de 2 000 000 000 points de données structurées dans les domaines des brevets, des sciences, des litiges et des technologies.
Innovez 75 % plus vite à un coût réduit de 25 %.
Cloud ou sur site pour une confidentialité et un contrôle maximaux
Reconnu par plus de 18 000 innovateurs à travers le monde
Pour l'utiliser, cliquez sur le bouton de vérification dans l'e-mail que nous avons envoyé à [email protected].
Cela contribue à sécuriser votre compte.
Vous devriez le recevoir sous peu. N'oubliez pas de vérifier votre dossier spam.
Unlock professional features and history
Already have an account? Log In
To start using PatSnap Eureka, click the verification button in the email we sent to .
This helps keep your account secure.
Haven't received it? Check your spam folder.
Série soigneusement sélectionnée offrant des informations précieuses aux professionnels de l'innovation.
Article | Rapport Explore the core engineering challenges of achieving consistent weld quality in robotic laser welding of battery enclosures — from defect control to adaptive process monitoring.
Article | Rapport How iptacopan and emerging oral Factor B inhibitors are reshaping PNH treatment by targeting the complement alternative pathway beyond C5 inhibition.
Article | Rapport Explore the core technical, operational, and infrastructure challenges of deploying private 5G networks in large industrial manufacturing facilities.
Article | Rapport Tolebrutinib is the first therapy to show efficacy in nrSPMS. Explore the CNS-penetrant BTK inhibitor's pharmacology, HERCULES trial data, and patent landscape.
Article | Rapport Compare digital image correlation (DIC) and traditional strain gauge measurement for structural testing: principles, accuracy, cost, and how to choose the right method.
Article | Rapport From STELLAR's Phase III results to HYPERION and ZENITH: how sotatercept is reshaping PAH treatment across all risk strata and disease stages.
Article | Rapport Explore the key engineering, operational, and infrastructure tradeoffs between hydrogen fuel cell and battery-electric powertrains for long-haul heavy-duty trucking.
Article | Rapport Pelacarsen's HORIZON Phase III trial is the first cardiovascular outcomes study for Lp(a) lowering. Explore the mechanism, trial design, and competitive landscape.
Article | Rapport How does silicon photonics differ from traditional fiber optics for data center interconnects? Engineering breakdown of integration, bandwidth, and cost trade-offs.
Article | Rapport What engineering challenges must be solved to build a 10MW floating offshore wind turbine? Structural dynamics, mooring, control, and installation — analysed.
Article | Rapport Cobenfy (xanomeline-trospium) leads a crowded muscarinic agonist pipeline for schizophrenia and Alzheimer's psychosis. Explore competitive readouts, key players, and patent trends for 2026.
Article | Rapport ViTs vs CNNs for industrial defect detection: how global self-attention compares to local convolution across accuracy, speed, and data requirements.
Article | Rapport Fazirsiran, ARO-AAT, and gene therapy are reshaping the AATD drug pipeline. Explore Phase 2 data, GalNAc delivery, and what Phase 3 means for liver disease.
Article | Rapport Key engineering considerations for MRI-compatible medical device design: material selection, lead safety, RF shielding, and adaptive implant strategies. Evidence from 50+ patents.
Article | Rapport Anito-cel, cilta-cel, ide-cel and next-generation BCMA CAR-T therapies in multiple myeloma: competitive landscape, IP strategy, and clinical signals analysed.